There is significant conjecture on the reasoning for and potential outcome of the FDA meeting in a very opaque process. My concern is that it is very unlikely that a definitive decision will result in the meeting. Given the heightened expectations some shareholders will be let down and it will create opportunity for the shorts to try and discredit. As much as I hope for good news ASAP, I would temper expectations.